We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund

112 hedge funds and large institutions have $1.32B invested in First Trust NYSE Arca Biotechnology Index Fund in 2014 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 33 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 8

100% more funds holding in top 10

Funds holding in top 10: 36 (+3)

42% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 33

39% more capital invested

Capital invested by funds: $949M → $1.32B (+$367M)

14% more funds holding

Funds holding: 98112 (+14)

2.37% more ownership

Funds ownership: 57.99%60.36% (+2.4%)

45% less call options, than puts

Call options by funds: $918K | Put options by funds: $1.68M

Holders
112
Holders Change
+14
Holders Change %
+14.29%
% of All Funds
2.99%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.16%
New
24
Increased
47
Reduced
33
Closed
8
Calls
$918K
Puts
$1.68M
Net Calls
-$765K
Net Calls Change
+$152K
Name Holding Trade Value Shares
Change
Change in
Stake
B
26
Baird
Wisconsin
$4.91M +$128K +1,315 +3%
JP Morgan Chase
27
JP Morgan Chase
New York
$4.87M -$2.21M -22,680 -32%
Citadel Advisors
28
Citadel Advisors
Florida
$4.48M +$4.29M +43,915 New
AIG
29
American International Group
New York
$3.73M -$122K -1,251 -3%
HighTower Advisors
30
HighTower Advisors
Illinois
$3.65M +$57.1K +585 +2%
RJFSA
31
Raymond James Financial Services Advisors
Florida
$3.57M +$272K +2,790 +9%
FMP
32
Financial Management Professionals
Texas
$3.54M +$3.39M +34,728 New
SB
33
Suntrust Banks
Georgia
$3.4M +$112K +1,146 +4%
PHS
34
Pekin Hardy Strauss
Illinois
$3.12M +$2.98M +30,551 New
WA
35
WESPAC Advisors
California
$3.12M +$2.98M +30,551 New
NA
36
NewEdge Advisors
Louisiana
$2.93M +$2.8M +28,697 New
AA
37
Ancora Advisors
Ohio
$2.61M -$24.4K -250 -1%
BCM
38
Beck Capital Management
Texas
$2.53M +$187K +1,918 +8%
IH
39
IFC Holdings
Florida
$2.48M -$159K -1,631 -6%
AP
40
Advisors Preferred
Maryland
$2.45M +$2.22M +22,738 +1,810%
Commonwealth Equity Services
41
Commonwealth Equity Services
Massachusetts
$2.44M +$409K +4,184 +21%
FHC
42
First Heartland Consultants
Missouri
$2.34M -$60K -614 -3%
UCFA
43
United Capital Financial Advisors
Texas
$2.32M +$721K +7,382 +48%
Deutsche Bank
44
Deutsche Bank
Germany
$2.3M +$210K +2,150 +11%
PI
45
Placemark Investments
Illinois
$2.13M +$178K +1,822 +10%
SG
46
Somerset Group
Minnesota
$2.12M +$3.38M +34,601 New
OC
47
Oppenheimer & Co
New York
$2.12M -$119K -1,214 -6%
SG Americas Securities
48
SG Americas Securities
New York
$2M +$1.48M +15,139 +340%
FAAS
49
First Allied Advisory Services
California
$1.94M -$319K -3,264 -15%
Cambridge Investment Research Advisors
50
Cambridge Investment Research Advisors
Iowa
$1.92M -$1.7M -17,451 -48%

FBT Hedge Fund Activity: Q4 2014 in Review

112 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q4 2014, worth a combined $1.32B — up 39% from $949M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new FBT positions and 8 closed out — a net gain of 16 holders — while 47 added to existing stakes and 33 trimmed.

The largest buyer was First Trust Advisors, adding an estimated $158M. The largest seller was RiverFront Investment Group, cutting an estimated $3.81M.

  • 112 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q4 2014, up from 98 in Q3 2014.
  • Funds reported $1.32B of First Trust NYSE Arca Biotechnology Index Fund stock for Q4 2014, up 39% quarter-over-quarter.
  • 24 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q4 2014 and 8 closed out, a net change of +16 holders.
  • The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q4 2014 was First Trust Advisors, an estimated $158M added.
  • The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q4 2014 was RiverFront Investment Group, an estimated $3.81M sold.

Based on aggregated 13F filings for Q4 2014.